In conclusion, we have demonstrated that the NTX could induce apoptosis through the decreased expression of APE-1 in TMZ-resistant GBM in vitro and inhibit the growth of a TMZ-resistant GBM tumor model, which is confirmed by a decreased tumor volume and an increased ADC after short-term NTX therapy in addition to extended survival. This evidence concerns the gene APEX1 and glioblastoma.